Tobias Bald

I am a tumor biologist and immunologist studying the phenotypic plasticity of cells in the tumor microenvironment.

[Niklas Klümper @niklas_kluemper]

In three Phase III trials (mUC: IMvigor211, mRCC: IMmotion151, NSCLC: OAK) immunotherapy prolonged OS when baseline serum albumin was >35g/L -> Prediction of less immune fitness via simple albumin measurement?https://t.co/NVAyxJznOH @OncoAlert @ClinTransImmuno @Doc_Bald @IEO_Bonn

[Michael Hölzel @HolzelMichael]

Excellent presentation by Gonzalo at the Single Domain Antibodies Meeting 2023 in Paris on his generic #CRISPR #CAR T cell platform! Important tool to improve #cellular #cancer #immunotherapies @UniBonn⁩ ⁦@ImmunoSens⁩ ⁦@MSSOabcd⁩ ⁦@IEO_GloddeLab⁩

[Niklas Klümper @niklas_kluemper]

Happy to share our work: Integrating On-Treatment Modified Glasgow Prognostic Score and Imaging to Predict Response and Outcomes in Metastatic Renal Cell Carcinoma @JAMAOnc. See our tweetorial and the terrific editorial by @ggebraelmd @GliceidaGalarza @neerajaiims @urotoday 1/7

[ImmunoSensation @ImmunoSens]

After 5 days of #science and networking, the ImmunoSensation2 SummerSchool "#Immunology at scales" comes to an end. We hope everyone had a great time at Schwanenwerda #Abendsonne 😉

Also want to be a #PhD #Student @ImmunoSens? 👉https://t.co/leRMZs6aLN

[Bonn & Melbourne Research and Graduate School @BonnMelbPhD]

Thanks to all participants of our retreat @UniBonn @UniMelb for interesting & inspiring talks, networking and great interactions - it was fun to meet in person again!

[Tobias Bald @Doc_Bald]

Well done Fenna!!! You are a fantastic PhD student keep up with the good science! Thanks @UniBonn, @UniMelb and @BonnMelbPhD for this great Retreat!

[Bonn & Melbourne Research and Graduate School @BonnMelbPhD]

Final day of our retreat: big thanks to Andreas @DrAndy92 & Abdalla @abdalla42353282 for sharing their experiences with the joint PhD @UniMelb @UniBonn & congratulations to Fenna Feenstra @IEO_baldlab & Helena @HelenaHorvatic for receiving our awards for the best talk/ poster 🏆

[Tobias Bald @Doc_Bald]

Longitudinal CRP kinetics (CRP Flare :fire:) predicts immunotherapy response within the first month in NSCLC! Great tool for therapy monitoring and as an integral biomarker for biomarker-directed study design @niklas_kluemper @Doc_Bald @IEO_BaldLab @IEO_Bonn @ImmunoSens @UniBonn

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC short report: C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer https://t.co/gzRGgwLi74 @niklas_kluemper @Doc_Bald

[IEO_Bonn @IEO_Bonn]

Longitudinal CRP kinetics (CRP Flare 🔥) predicts immunotherapy response within the first month in NSCLC! Great tool for therapy monitoring and as an integral biomarker for biomarker-directed study design @niklas_kluemper @Doc_Bald @IEO_BaldLab @IEO_Bonn @ImmunoSens @UniBonn

[Bonn & Melbourne Research and Graduate School @BonnMelbPhD]

We are excited to welcome Prof Tobias Bald @IEO_baldlab @UniBonn & Prof @MarcoHerold_J @WEHI_research @UniMelbMDHS as new PIs to our program! DFG funding @dfg_public for their project investigating CD155-CD226 interactions for T cell functionality in cancer has been approved 🥳

[IEO_HölzelLab @IEO_HolzelLab]

CRP as biomarker to predict responses to immune checkpoint inhibitors in patients with metastatic renal cancer. Great potential for the clinic as simple and cost-effective. Congrats to @niklas_kluemper @UniklinikBonn and collaborators.

https://t.co/2qFdb8c9dX

[IEO_Bonn @IEO_Bonn]

New paper published by Klümper et al. about CRP as a biomarker in metastatic renal cancer. Congratulations to all collaborators🎉@niklas_kluemper

[IEO_Bonn @IEO_Bonn]

🥳Attention science enthusiasts🥳We are excited to announce the launch of our new IEO website. Check it out to find out more about our research and spread the word 🎉https://t.co/uNcbhG9ORd @ImmunoSens @HCM_Bonn @UniklinikBonn @UniBonn

[Prof. Karl Lauterbach @Karl_Lauterbach]

Dieser Text von Paul Offit, dem führenden Kinder Impfspezialisten in den USA, erklärt überzeugend, weshalb auch Kinder im Alter 5-12 J geimpft werden sollten. Sehr lesenswert. Den Impfstoff werden wir bald auch in Deutschland haben, ich schätze vor Weihnachten

[isb_bonn @IsbBonn]

We are happy to share the most recent publication from our Institute by PhD student @InesKalt describing Hip Kinases as a target of the FDA approved cancer drug Abemaciclib. Read the full article in @NatureComms here: https://t.co/9XmD9MqJAw

[Tobias Bald @Doc_Bald]

@DrAshHaque Is this your lockdown look or were you imprisoned 😂

[Tobias Bald @Doc_Bald]

@ImmunoSens @UniBonn @UniklinikBonn @IEO_baldlab It’s a great honor to receive this prestigious award! Also a huge congrats to Sebastian Kobold @LMU_Muenchen Well deserved!

[ImmunoSensation @ImmunoSens]

👏Congratulations to @Doc_Bald for recieving the Lisec-Artz Prize, together with Sebastian Kobold! Well deserved! @UniBonn @UniklinikBonn @IEO_baldlab

[Jonathan Schmid-Burgk @schmidburgk]

LAMP-Seq with 1-enzyme protocol out today https://t.co/MmBETJk5fN, grateful to colleagues @ Bonn&Boston! @k_u_ludwig @RSchmithausen @_David_Li @ronhollstein @biomiko @NIshorst @LMHighfield @evabeins @InesKalt @MaxSticks7 @ern_esth @jacobborrajo @thestrecker @HolzelMichael @zhangf

[Kerstin Ludwig @k_u_ludwig]

Absolutely thrilled to see this work finally published! About 15 months ago I started on a journey which I could not have imagined before… Interested in the story behind the scenes? My first-ever thread. 1/n